Associate Professor Janette Vardy

Principal Research Fellow
Medicine, Concord Clinical School

Telephone 9767 5000

Map

Selected grants

2014

  • Healthy Living after Cancer; Eakin E, Hayes S, Haas M, Reeves M, Vardy J, Boyle F, Hiller J, Mishra G, Jefford M; National Health and Medical Research Council (NHMRC)/Partnership Projects.

2013

  • PoCoG infrastructure to support operational activity and facility management to further psychosocial and supportive care clinical trials; Butow P, Girgis A, Kelly B, Vardy J, Dhillon H, Hobbs K, Price M; Cancer Institute New South Wales/Cooperative Clinical Trial (CCT) Grants.
  • Evaluation of a web-based cognitive rehabilitation programme in cancer survivors with self-reported cognitive impairment; Vardy J, Dhillon H, Bell M, Price M, Cysique L, Bray V; Cancer Council New South Wales/Research Project Grants.

2012

  • The impact of physical activity on fatigue and quality of life in lung cancer patients; Vardy J, Clarke S, Dhillon H, Boyer M; Slater and Gordon Asbestos Research Fund/Vojakovic Fellowship.
  • Cognitive rehabilitation for breast cancer survivors with perceived cognitive impairment; Vardy J; American Society of Clinical Oncology (USA)/Research Support.
  • Review and Update of Psychosocial Clinical Practice Guidelines; Butow P, Olver I, Price M, Vardy J, Dhillon H, Thewes B, Best M, Peate M; Cancer Australia/Tender: Systematic reviews to support clinical practice guidelines.
  • Ginkgo biloba preserves cognitive function in women treated with adjuvant chemotherapy for early breast cancer: a double-blind, placebo-controlled, randomised phase III trial; Tattersall M, Vardy J, Dhillon H, Bell M, Cysique L, Boyle F, Clarke S; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.
  • Objective Measurement of Physical Activity and Sedentary Behaviours across Twelve NHMRC Funded Studies; Baur L, Van Der Ploeg H, Tiedemann A, Vardy J, Dhillon H, Maher C, Lin C, Chau J, Hardy L, Rissel C, Latimer J, Moseley A, Bauman A; National Health and Medical Research Council (NHMRC)/Equipment Grants.

2011

  • Evaluation of a web-based cognitive rehabilitation programme in cancer survivors with self-reported cognitive impairment; Bray V, Vardy J; Clinical Oncological Society of Australia/Research Support.

2010

  • Cognitive function and fatigue in cancer patients after chemotherapy: A longitudinal controlled study in patients with colorectal cancer; Vardy J; Concord Hospital/Oncology Patient Donation Fund.
  • Cognitive Function and Survivorship; Vardy J; Cancer Institute New South Wales/Clinical Research Fellowship (CRF).
  • Cognitive function and fatigue in cancer survivors; Vardy J; Cancer Institute New South Wales/Clinical Research Fellowship (CRF).
  • Evaluation of a Web-based Cognitive Rehabilitation Programme in Cancer Survivors with Self Reported Cognitive Impairment; Bray V, Vardy J, Dhillon H, Boyle F; Friends of the Mater/Annual Grant.
  • Efficacy and safety of Gingko biloba for cognitive function in breast cancer patients undergoing adjuvant chemotherapy; Vardy J, Dhillon N, Boyle F; Friends of the Mater/Annual Grant.

2009

  • Caring for thoracic cancer caregivers: Exploring psychological and supportive care needs; Wikaire E, Vardy J, Dhillon H, Price M; Australian Lung Foundation/ALTG Concept Development Grant.
  • Clinical Studies of the Efficacy and Tolerability of Systemically Administered Complementary and Alternative Medicine (CAM) in Conjunction with Standary Therapy in Cancer Patients; Vardy J, Clarke S; National Center for Complementary Medicine /Integrated Care Research Program.
  • The Psycho-oncology Co-operative Group: infrastructure to support operational activity and facility management to further psychosocial research and quality of life studies in clinical trials; Butow P, Meiser B, Girgis A, King M, Vardy J, White K, Rankin N, Price M, Girgis A, Meiser B; Cancer Institute New South Wales/Infrastructure Grant.
  • Gymnasium equipment for Sydney Cancer Centre physical activity program; Vardy J; Sydney Cancer Centre Foundation/Capital Works & Equipment Grant.
  • Phase III Study of the impact of a physical activity program on disease-free survival for early colon cancer; Vardy J, Zalcberg J, Dhillon H, Van Der Ploeg H, Courneya K, Meyer R; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Developing an animal model to study the long-term impact of chemotherapy on cognition, mood, pain and general health; Vardy J; DVC Research/Cancer Research Fund.
  • The impact of physical activity on quality of life in lung cancer patients; Vardy J, Dhillon H; Lance Armstrong Foundation/Young Investigator Grant.
  • The impact of physical activity on quality of life in thoracic cancer patients; Vardy J, Dhillon H, Van Der Ploeg H, Clarke S, Boyer M, Bauman A; Lance Armstrong Foundation/Young Investigator Grant.
  • CHALLENGE: Colon Health and Life Long Exercise Change; Courneya K, Vardy J, Meyer R, Dhillon H, Van Der Ploeg H, Zalcberg J; National Health and Medical Research Council (NHMRC)/Project: Large Scale Clinical Trial Grant.

2008

  • Efficacy and Safety of Ginkgo Biloba for cognition function and fatigue in breast cancer patients undergoing adjuvant chemotherapy; Vardy J; American Society of Clinical Oncology (USA)/Career Development Award (CDA).
  • Gingko Biloba for cognitive function and fatigue in breast cancer patients; Vardy J; American Society of Clinical Oncology (USA)/Career Development Award (CDA).
  • Cognitive rehabilitation for breast cancer survivors with perceived cognitive impairment; Vardy J, Dhillon H; Cancer Institute New South Wales/Sponsorship.

2007

  • Characterisation of congnitive impairment in colectoral cancer patients and underlying mechanisms; Vardy J; Pfizer Australia/Neuroscience Research Grants.
  • Cognitive Function and Fatigue in cancer patients after chemotherapy; Vardy J, Clarke S, Tannock I, Schnitzler M, Dhillon H; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Ahles, T., Schagen, S., Vardy, J. (2012). Neurocognitive Effects of Anticancer Treatments. In Luigi Grassi, Michelle Riba (Eds.), Clinical Psycho-Oncology: An International Perspective, (pp. 71-82). Chichester: Wiley-Blackwell Publishing.
  • Vardy, J., Dhillon, H. (2011). Cognitive Function in Cancer Survivors. In M. P. Davis, P. Feyer, P, Ortner and C. Zimmermann (Eds.), Supportive Oncology, (pp. 448-455). Philadelphia: Elsevier.
  • Vardy, J., Dhillon, H. (2010). Clinical Trials in Survivors of Cancer with Chemotherapy Related Cognitive Impairment. American Society of Clinical Oncology 2010 Educational Book, (pp. 56-59). United States: American Society of Clinical Oncology.
  • Vardy, J. (2009). Cognitive function in breast cancer survivors. In Castiglione, Monica; Piccart, Martine (Eds.), Adjuvant Therapy for Breast Cancer, (pp. 387-419). New York, United States: Springer.

Journals

  • Selamat, M., Loh, S., Mackenzie, L., Vardy, J. (2014). Chemobrain experienced by breast cancer survivors: A meta-ethnography study investigating research and care implications. PLoS One, 9(9), 1-12.
  • Goldstein, D., Bell, M., Butow, P., Sze, M., Vaccaro, L., Dong, S., Liauw, W., Hui, R., Tattersall, M., Ng, W., Vardy, J., King, M., et al (2014). Immigrants' perceptions of the quality of their cancer care: an Australian comparative study, identifying potentially modifiable factors. Annals of Oncology, 25, 1643-1649. [More Information]
  • Sonpavde, G., Pond, G., Armstrong, A., Clarke, S., Vardy, J., Templeton, A., Wang, S., Paolini, J., Chen, I., Chow-Maneval, E., et al (2014). Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer, 12(5), 317-324. [More Information]
  • Fardell, J., Zhang, J., De Souza, R., Vardy, J., Johnston, I., Allen, C., Henderson, J., Piquette-Miller, M. (2014). The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy mice. Psychopharmacology, 231(5), 841-852. [More Information]
  • Kao, S., Lee, K., Klebe, S., Henderson, D., McCaughan, B., Vardy, J., Clarke, S., van Zandwijk, N. (2013). Excision Repair Cross Complementation Group 1 and Thymidylate Synthase Expression in Patients With Mesothelioma. Clinical Lung Cancer, 14(2), 164-171. [More Information]
  • Linton, A., Pond, G., Clarke, S., Vardy, J., Galsky, M., Sonpavde, G. (2013). Glasgow Prognostic Score As a Prognostic Factor in Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel-Based Chemotherapy. Clinical Genitourinary Cancer, 11(4), 423-430. [More Information]
  • Kao, S., Vardy, J., Harvie, R., Chatfield, M., van Zandwijk, N., Clarke, S., Pavlakis, N. (2013). Health-related quality of life and inflammatory markers in malignant pleural mesothelioma. Supportive Care in Cancer, 21(3), 697-705. [More Information]
  • Linton, A., Kao, S., Vardy, J., Clarke, S., van Zandwijk, N., Klebe, S. (2013). Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: Trends in Australia and a literature review. Asia-Pacific Journal of Clinical Oncology, 9(3), 273-279. [More Information]
  • Vardy, J., Dhillon, H., Clarke, S., Olesen, I., Leslie, F., Warby, A., Beith, J., Sullivan, A., Hamilton, A., Beale, P., Rittau, A., McLachlan, A. (2013). Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer. SpringerPlus, 2(1), 1-5. [More Information]
  • Kao, S., Clarke, S., Vardy, J., Corte, P., Clarke, C., van Zandwijk, N. (2013). Patterns of care for malignant pleural mesothelioma patients compensated by the Dust Diseases Board in New South Wales, Australia. Internal Medicine Journal, 43(4), 402-410. [More Information]
  • Butow, P., Sze, M., Eisenbruch, M., Bell, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., Hui, R., et al (2013). Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients. Patient Education and Counseling, 92(2), 246-252. [More Information]
  • Fardell, J., Vardy, J., Johnston, I. (2013). The short and long term effects of docetaxel chemotherapy on rodent object recognition and spatial reference memory. Life Sciences, 93(17), 596-604. [More Information]
  • Kao, S., van Zandwijk, N., Corte, P., Clarke, C., Clarke, S., Vardy, J. (2013). Use of cancer therapy at the end of life in patients with malignant pleural mesothelioma. Supportive Care in Cancer, 21(7), 1879-1884. [More Information]
  • Kao, S., Vardy, J., Chatfield, M., Corte, P., Pavlakis, N., Clarke, C., van Zandwijk, N., Clarke, S. (2013). Validation of Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Analysis of Data from Patients Seeking Compensation from the New South Wales Dust Diseases Board. Clinical Lung Cancer, 14(1), 70-77. [More Information]
  • Hillen, M., Butow, P., Tattersall, M., Hruby, G., Boyle, F., Vardy, J., Kallimanis-King, B., de Haes, H., Smets, E. (2013). Validation of the English version of the Trust in Oncologist Scale (TiOS). Patient Education and Counseling, 91(1), 25-28. [More Information]
  • Vardy, J., Pond, G., Dodd, A., Warr, D., Seruga, B., Clemons, M., Bordeleau, L., Goodwin, P., Tannock, I. (2012). A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment, 136(1), 143-151. [More Information]
  • Fardell, J., Vardy, J., Shah, J., Johnston, I. (2012). Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychopharmacology, 220(1), 183-193. [More Information]
  • Oh, B., Butow, P., Mullan, B., Clarke, S., Beale, P., Pavlakis, N., Lee, M., Rosenthal, D., Larkey, L., Vardy, J. (2012). Effect of Medical Qigong on Cognitive function, Quality of Life and a Biomarker of Inflammation in Cancer Patients: A Randomized Controlled Trial. Supportive Care in Cancer, 20(6), 1235-1242. [More Information]
  • Mitchison, D., Butow, P., Sze, M., Aldridge, L., Hui, R., Vardy, J., Eisenbruch, M., Iedema, R., Goldstein, D. (2012). Prognostic communication preferences of migrant patients and their relatives. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 21(5), 496-504. [More Information]
  • Sharpe, M., Fardell, J., Vardy, J., Johnston, I. (2012). The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in rats. Behavioural Brain Research, 227(1), 295-299. [More Information]
  • Clarey, J., Kao, S., Clarke, S., Vardy, J. (2012). The eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trials. Annals of Oncology, 23(5), 1229-1233. [More Information]
  • Dhillon, H., Van Der Ploeg, H., Bell, M., Boyer, M., Clarke, S., Vardy, J. (2012). The impact of physical activity on fatigue and quality of life in lung cancer patients: A randomised controlled trial protocol. BMC Cancer, 12, 1-9. [More Information]
  • Linton, A., Vardy, J., Clarke, S., van Zandwijk, N. (2012). The ticking time-bomb of asbestos: Its insidious role in the development of malignant mesothelioma. Critical Reviews in Oncology / Hematology (online), 84(2), 200-212. [More Information]
  • Kao, S., Yan, T., Lee, K., Burn, J., Henderson, D., Klebe, S., Kennedy, C., Vardy, J., Clarke, S., Van Zandwijk, N., et al (2011). Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma. Journal of Thoracic Oncology, 6(3), 602-605. [More Information]
  • Fardell, J., Vardy, J., Johnston, I., Winocur, G. (2011). Chemotherapy and Cognitive Impairment: Treatment Options. Clinical Pharmacology and Therapeutics, 90(3), 366-376. [More Information]
  • Wefel, J., Vardy, J., Ahles, T., Schagen, S. (2011). International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncology, 12(7), 703-708. [More Information]
  • Butow, P., Goldstein, D., Bell, M., Sze, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., et al (2011). Interpretation in Consultations With Immigrant Patients With Cancer: How Accurate Is It? Journal of Clinical Oncology, 29(20), 2801-2807. [More Information]
  • Kao, S., Klebe, S., Henderson, D., Reid, G., Chatfield, M., Armstrong, N., Yan, T., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011). Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology, 6(11), 1923-1929. [More Information]
  • Kao, S., Griggs, K., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Burn, J., McCaughan, B., Henderson, D., et al (2011). Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma. Pathology, 43(4), 313-317. [More Information]
  • Kao, S., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Reid, G., Burn, J., McCaughan, B., Henderson, D., et al (2011). Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology, 43(2), 128-132. [More Information]
  • Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011). Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC Cancer, 11(142), 1-8. [More Information]
  • Kao, S., Pavlakis, N., Harvie, R., Vardy, J., Boyer, M., van Zandwijk, N., Clarke, S. (2010). High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clinical Cancer Research, 16(23), 5805-5813. [More Information]
  • Kao, S., Reid, G., Lee, K., Vardy, J., Clarke, S., van Zandwijk, N. (2010). Malignant Mesothelioma. International Medical Journal. [More Information]
  • Kao, S., Butow, P., Bray, V., Clarke, S., Vardy, J. (2010). Patient and oncologist estimates of survival in advanced cancer patients. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 10(2), 213-218.
  • Oh, B., Butow, P., Mullan, B., Clarke, S., Tattersall, M., Boyer, M., Beale, P., Vardy, J., Pavlakis, N., Larke, L. (2010). Patient-Doctor Communication: Use of Complementary and Alternative Medicine by Adult Patients with Cancer. Journal of the Society for Integrative Oncology, 8(2), 56-64. [More Information]
  • Fardell, J., Vardy, J., Logge, W., Johnston, I. (2010). Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents. Pharmacology, Biochemistry and Behavior, 97(2), 333-339. [More Information]
  • Vardy, J., Dhillon, H. (2010). The fog hasn't lifted on "chemobrain" yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition. Breast Cancer Research and Treatment, 123(1), 35-37. [More Information]
  • Vardy, J. (2009). Cognitive function in survivors of cancer. American Society of Clinical Oncology Educational Book, 1, 570-574.
  • Vardy, J., Dadasovich, R., Beale, P., Boyer, M., Clarke, S. (2009). Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials. BMC Cancer, 9(Article number 130), 130-1-130-6. [More Information]
  • Lai, J., Butt, Z., Wagner, L., Sweet, J., Beaumont, J., Vardy, J., Jacobsen, P., Shapiro, P., Jacobs, S., Cella, D. (2009). Evaluating the dimensionality of perceived cognitive function. Journal of Pain and Symptom Management, 37(6), 982-995. [More Information]
  • Pollard, A., Eakin, E., Vardy, J., Hawkes, A. (2009). Health behaviour interventions for cancer survivors: An overview of the evidence and contemporary Australian trials. Cancer Forum, 33(3), 182-186.
  • Kao, S., Shafiq, J., Vardy, J., Adams, D. (2009). Use of chemotherapy at end of life in oncology patients. Annals of Oncology, 20(9), 1555-1559. [More Information]
  • Vardy, J., Wefel, J., Ahles, T., Tannock, I., Schagen, S. (2008). Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice Cognitive Workshop. Annals of Oncology, 19(4), 623-629. [More Information]
  • Chiew, K., Shepherd, H., Vardy, J., Tattersall, M., Butow, P., Leighl, N. (2008). Development and evaluation of a decision aid for patients considering first-line chemotherapy for metastatic breast cancer. Health expectations : an international journal of public participation in health care and health policy, 11(1), 35-45.
  • Vardy, J. (2008). Neurocognitive Effects of Chemotherapy in Adults. Australian Prescriber, 31(1), 22-24.
  • Courneya, K., Booth, C., Gill, S., O'Brien, P., Vardy, J., Friedenreich, C., Au, H., Brundage, M., Tu, D., Dhillon, H., et al (2008). The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group. Current Oncology, 15(6), 8-16. [More Information]
  • Vardy, J., Schagen, S. (2007). Cognitive Dysfunction in People with Cancer. Lancet Oncology, 8(10), 852-853. [More Information]
  • Vardy, J., Tannock, I. (2007). Cognitive Function After Chemotherapy in Adults with Solid Tumours. Critical Reviews in Oncology / Hematology, 63(3), 183-202. [More Information]
  • Vardy, J., Rourke, S., Tannock, I. (2007). Evaluation of Cognitive Function Associated With Chemotherapy: A Review of Published Studies and Recommendations for Future Research. Journal of Clinical Oncology, 25(17), 2455-2463. [More Information]
  • Joly, F., Vardy, J., Pintilie, M., Tannock, I. (2007). Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Annals of Oncology, 18(12), 1935-1942. [More Information]
  • Vardy, J., Wong, K., Yi, Q., Park, A., Maruff, P., Wagner, L., Tannock, I. (2006). Assessing cognitive function in cancer patients. Supportive Care in Cancer, 14(11), 1111-1118. [More Information]
  • Vardy, J., Chiew, K., Galica, J., Pond, G., Tannock, I. (2006). Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. British Journal of Cancer, 94(7), 1011-1015. [More Information]
  • Winocur, G., Vardy, J., Binns, M., Kerr, L., Tannock, I. (2006). The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacology, Biochemistry and Behavior, 85(1), 66-75. [More Information]
  • Vardy, J., Joshua, A., Clarke, S., Yarrow, P., Lin, B. (2005). Small blue cell tumors of the rectum: CASE 1. Ewing's sarcoma of the rectum. Journal of Clinical Oncology, 23(4), 910-912. [More Information]
  • Stockler, M., Vardy, J., Pillai, A., Warr, D. (2004). Acetaminophen (Paracetamol) Improves Pain And Well-Being In People With Advanced Cancer Already Receiving A Strong Opioid Regimen: A Randomized, Double-Blind, Placebo-Controlled Cross-Over Trial. Journal of Clinical Oncology, 22(16), 3389-3394.
  • Vardy, J., Engelhardt, K., Cox, K., Jacquet, J., McDade, A., Boyer, M., Beale, P., Clarke, S., Stockler, M., Loneragan, R., Waugh, R., Clarke, S. (2004). Long-Term Outcome Of Radiological-Guided Insertion Of Implanted Central Venous Access Port Devices (Cvapd) For The Delivery Of Chemotherapy In Cancer Patients: Institutional Experience And Review Of The Literature. British Journal of Cancer, 91(6), 1045-1049.
  • Vardy, J., Tannock, I. (2004). Quality of cancer care. Annals of Oncology, 15(7), 1001-1006.
  • Vardy, J., Wong, E., Izard, M., Clifford, A., Clarke, S. (2002). Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review. Anti-Cancer Drugs, 13(3), 327-330.

2014

  • Selamat, M., Loh, S., Mackenzie, L., Vardy, J. (2014). Chemobrain experienced by breast cancer survivors: A meta-ethnography study investigating research and care implications. PLoS One, 9(9), 1-12.
  • Goldstein, D., Bell, M., Butow, P., Sze, M., Vaccaro, L., Dong, S., Liauw, W., Hui, R., Tattersall, M., Ng, W., Vardy, J., King, M., et al (2014). Immigrants' perceptions of the quality of their cancer care: an Australian comparative study, identifying potentially modifiable factors. Annals of Oncology, 25, 1643-1649. [More Information]
  • Sonpavde, G., Pond, G., Armstrong, A., Clarke, S., Vardy, J., Templeton, A., Wang, S., Paolini, J., Chen, I., Chow-Maneval, E., et al (2014). Prognostic Impact of the Neutrophil-to-Lymphocyte Ratio in Men With Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer, 12(5), 317-324. [More Information]
  • Fardell, J., Zhang, J., De Souza, R., Vardy, J., Johnston, I., Allen, C., Henderson, J., Piquette-Miller, M. (2014). The impact of sustained and intermittent docetaxel chemotherapy regimens on cognition and neural morphology in healthy mice. Psychopharmacology, 231(5), 841-852. [More Information]

2013

  • Kao, S., Lee, K., Klebe, S., Henderson, D., McCaughan, B., Vardy, J., Clarke, S., van Zandwijk, N. (2013). Excision Repair Cross Complementation Group 1 and Thymidylate Synthase Expression in Patients With Mesothelioma. Clinical Lung Cancer, 14(2), 164-171. [More Information]
  • Linton, A., Pond, G., Clarke, S., Vardy, J., Galsky, M., Sonpavde, G. (2013). Glasgow Prognostic Score As a Prognostic Factor in Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel-Based Chemotherapy. Clinical Genitourinary Cancer, 11(4), 423-430. [More Information]
  • Kao, S., Vardy, J., Harvie, R., Chatfield, M., van Zandwijk, N., Clarke, S., Pavlakis, N. (2013). Health-related quality of life and inflammatory markers in malignant pleural mesothelioma. Supportive Care in Cancer, 21(3), 697-705. [More Information]
  • Linton, A., Kao, S., Vardy, J., Clarke, S., van Zandwijk, N., Klebe, S. (2013). Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: Trends in Australia and a literature review. Asia-Pacific Journal of Clinical Oncology, 9(3), 273-279. [More Information]
  • Vardy, J., Dhillon, H., Clarke, S., Olesen, I., Leslie, F., Warby, A., Beith, J., Sullivan, A., Hamilton, A., Beale, P., Rittau, A., McLachlan, A. (2013). Investigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer. SpringerPlus, 2(1), 1-5. [More Information]
  • Kao, S., Clarke, S., Vardy, J., Corte, P., Clarke, C., van Zandwijk, N. (2013). Patterns of care for malignant pleural mesothelioma patients compensated by the Dust Diseases Board in New South Wales, Australia. Internal Medicine Journal, 43(4), 402-410. [More Information]
  • Butow, P., Sze, M., Eisenbruch, M., Bell, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., Hui, R., et al (2013). Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patients. Patient Education and Counseling, 92(2), 246-252. [More Information]
  • Fardell, J., Vardy, J., Johnston, I. (2013). The short and long term effects of docetaxel chemotherapy on rodent object recognition and spatial reference memory. Life Sciences, 93(17), 596-604. [More Information]
  • Kao, S., van Zandwijk, N., Corte, P., Clarke, C., Clarke, S., Vardy, J. (2013). Use of cancer therapy at the end of life in patients with malignant pleural mesothelioma. Supportive Care in Cancer, 21(7), 1879-1884. [More Information]
  • Kao, S., Vardy, J., Chatfield, M., Corte, P., Pavlakis, N., Clarke, C., van Zandwijk, N., Clarke, S. (2013). Validation of Prognostic Factors in Malignant Pleural Mesothelioma: A Retrospective Analysis of Data from Patients Seeking Compensation from the New South Wales Dust Diseases Board. Clinical Lung Cancer, 14(1), 70-77. [More Information]
  • Hillen, M., Butow, P., Tattersall, M., Hruby, G., Boyle, F., Vardy, J., Kallimanis-King, B., de Haes, H., Smets, E. (2013). Validation of the English version of the Trust in Oncologist Scale (TiOS). Patient Education and Counseling, 91(1), 25-28. [More Information]

2012

  • Vardy, J., Pond, G., Dodd, A., Warr, D., Seruga, B., Clemons, M., Bordeleau, L., Goodwin, P., Tannock, I. (2012). A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment, 136(1), 143-151. [More Information]
  • Fardell, J., Vardy, J., Shah, J., Johnston, I. (2012). Cognitive impairments caused by oxaliplatin and 5-fluorouracil chemotherapy are ameliorated by physical activity. Psychopharmacology, 220(1), 183-193. [More Information]
  • Oh, B., Butow, P., Mullan, B., Clarke, S., Beale, P., Pavlakis, N., Lee, M., Rosenthal, D., Larkey, L., Vardy, J. (2012). Effect of Medical Qigong on Cognitive function, Quality of Life and a Biomarker of Inflammation in Cancer Patients: A Randomized Controlled Trial. Supportive Care in Cancer, 20(6), 1235-1242. [More Information]
  • Ahles, T., Schagen, S., Vardy, J. (2012). Neurocognitive Effects of Anticancer Treatments. In Luigi Grassi, Michelle Riba (Eds.), Clinical Psycho-Oncology: An International Perspective, (pp. 71-82). Chichester: Wiley-Blackwell Publishing.
  • Mitchison, D., Butow, P., Sze, M., Aldridge, L., Hui, R., Vardy, J., Eisenbruch, M., Iedema, R., Goldstein, D. (2012). Prognostic communication preferences of migrant patients and their relatives. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 21(5), 496-504. [More Information]
  • Sharpe, M., Fardell, J., Vardy, J., Johnston, I. (2012). The chemotherapy agent oxaliplatin impairs the renewal of fear to an extinguished conditioned stimulus in rats. Behavioural Brain Research, 227(1), 295-299. [More Information]
  • Clarey, J., Kao, S., Clarke, S., Vardy, J. (2012). The eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trials. Annals of Oncology, 23(5), 1229-1233. [More Information]
  • Dhillon, H., Van Der Ploeg, H., Bell, M., Boyer, M., Clarke, S., Vardy, J. (2012). The impact of physical activity on fatigue and quality of life in lung cancer patients: A randomised controlled trial protocol. BMC Cancer, 12, 1-9. [More Information]
  • Linton, A., Vardy, J., Clarke, S., van Zandwijk, N. (2012). The ticking time-bomb of asbestos: Its insidious role in the development of malignant mesothelioma. Critical Reviews in Oncology / Hematology (online), 84(2), 200-212. [More Information]

2011

  • Kao, S., Yan, T., Lee, K., Burn, J., Henderson, D., Klebe, S., Kennedy, C., Vardy, J., Clarke, S., Van Zandwijk, N., et al (2011). Accuracy of diagnostic biopsy for the histological subtype of malignant pleural mesothelioma. Journal of Thoracic Oncology, 6(3), 602-605. [More Information]
  • Fardell, J., Vardy, J., Johnston, I., Winocur, G. (2011). Chemotherapy and Cognitive Impairment: Treatment Options. Clinical Pharmacology and Therapeutics, 90(3), 366-376. [More Information]
  • Vardy, J., Dhillon, H. (2011). Cognitive Function in Cancer Survivors. In M. P. Davis, P. Feyer, P, Ortner and C. Zimmermann (Eds.), Supportive Oncology, (pp. 448-455). Philadelphia: Elsevier.
  • Wefel, J., Vardy, J., Ahles, T., Schagen, S. (2011). International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncology, 12(7), 703-708. [More Information]
  • Butow, P., Goldstein, D., Bell, M., Sze, M., Aldridge, L., Abdo, S., Mikhail (nee Tanious), M., Dong, S., Iedema, R., Vardy, J., et al (2011). Interpretation in Consultations With Immigrant Patients With Cancer: How Accurate Is It? Journal of Clinical Oncology, 29(20), 2801-2807. [More Information]
  • Kao, S., Klebe, S., Henderson, D., Reid, G., Chatfield, M., Armstrong, N., Yan, T., Vardy, J., Clarke, S., van Zandwijk, N., McCaughan, B. (2011). Low Calretinin Expression and High Neutrophil-To-Lymphocyte Ratio Are Poor Prognostic Factors in Patients with Malignant Mesothelioma Undergoing Extrapleural Pneumonectomy. Journal of Thoracic Oncology, 6(11), 1923-1929. [More Information]
  • Kao, S., Griggs, K., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Burn, J., McCaughan, B., Henderson, D., et al (2011). Validation of a minimal panel of antibodies for the diagnosis of malignant pleural mesothelioma. Pathology, 43(4), 313-317. [More Information]
  • Kao, S., Lee, K., Armstrong, N., Clarke, S., Vardy, J., van Zandwijk, N., Reid, G., Burn, J., McCaughan, B., Henderson, D., et al (2011). Validation of tissue microarray technology in malignant pleural mesothelioma. Pathology, 43(2), 128-132. [More Information]
  • Fogarty, G., Morton, R., Vardy, J., Nowak, A., Mandel, C., Forder, P., Hong, A., Hruby, G., Burmeister, B., Shivalingam, B., Dhillon, H., Thompson, J. (2011). Whole brain radiotherapy after local treatment of brain metastases in melanoma patients - a randomised phase III trial. BMC Cancer, 11(142), 1-8. [More Information]

2010

  • Vardy, J., Dhillon, H. (2010). Clinical Trials in Survivors of Cancer with Chemotherapy Related Cognitive Impairment. American Society of Clinical Oncology 2010 Educational Book, (pp. 56-59). United States: American Society of Clinical Oncology.
  • Kao, S., Pavlakis, N., Harvie, R., Vardy, J., Boyer, M., van Zandwijk, N., Clarke, S. (2010). High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clinical Cancer Research, 16(23), 5805-5813. [More Information]
  • Kao, S., Reid, G., Lee, K., Vardy, J., Clarke, S., van Zandwijk, N. (2010). Malignant Mesothelioma. International Medical Journal. [More Information]
  • Kao, S., Butow, P., Bray, V., Clarke, S., Vardy, J. (2010). Patient and oncologist estimates of survival in advanced cancer patients. Psycho-Oncology: journal of the psychological, social and behavioral dimensions of cancer, 10(2), 213-218.
  • Oh, B., Butow, P., Mullan, B., Clarke, S., Tattersall, M., Boyer, M., Beale, P., Vardy, J., Pavlakis, N., Larke, L. (2010). Patient-Doctor Communication: Use of Complementary and Alternative Medicine by Adult Patients with Cancer. Journal of the Society for Integrative Oncology, 8(2), 56-64. [More Information]
  • Fardell, J., Vardy, J., Logge, W., Johnston, I. (2010). Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents. Pharmacology, Biochemistry and Behavior, 97(2), 333-339. [More Information]
  • Vardy, J., Dhillon, H. (2010). The fog hasn't lifted on "chemobrain" yet: ongoing uncertainty regarding the effects of chemotherapy and breast cancer on cognition. Breast Cancer Research and Treatment, 123(1), 35-37. [More Information]

2009

  • Vardy, J. (2009). Cognitive function in breast cancer survivors. In Castiglione, Monica; Piccart, Martine (Eds.), Adjuvant Therapy for Breast Cancer, (pp. 387-419). New York, United States: Springer.
  • Vardy, J. (2009). Cognitive function in survivors of cancer. American Society of Clinical Oncology Educational Book, 1, 570-574.
  • Vardy, J., Dadasovich, R., Beale, P., Boyer, M., Clarke, S. (2009). Eligibility of patients with advanced non-small cell lung cancer for phase III chemotherapy trials. BMC Cancer, 9(Article number 130), 130-1-130-6. [More Information]
  • Lai, J., Butt, Z., Wagner, L., Sweet, J., Beaumont, J., Vardy, J., Jacobsen, P., Shapiro, P., Jacobs, S., Cella, D. (2009). Evaluating the dimensionality of perceived cognitive function. Journal of Pain and Symptom Management, 37(6), 982-995. [More Information]
  • Pollard, A., Eakin, E., Vardy, J., Hawkes, A. (2009). Health behaviour interventions for cancer survivors: An overview of the evidence and contemporary Australian trials. Cancer Forum, 33(3), 182-186.
  • Kao, S., Shafiq, J., Vardy, J., Adams, D. (2009). Use of chemotherapy at end of life in oncology patients. Annals of Oncology, 20(9), 1555-1559. [More Information]

2008

  • Vardy, J., Wefel, J., Ahles, T., Tannock, I., Schagen, S. (2008). Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice Cognitive Workshop. Annals of Oncology, 19(4), 623-629. [More Information]
  • Chiew, K., Shepherd, H., Vardy, J., Tattersall, M., Butow, P., Leighl, N. (2008). Development and evaluation of a decision aid for patients considering first-line chemotherapy for metastatic breast cancer. Health expectations : an international journal of public participation in health care and health policy, 11(1), 35-45.
  • Vardy, J. (2008). Neurocognitive Effects of Chemotherapy in Adults. Australian Prescriber, 31(1), 22-24.
  • Courneya, K., Booth, C., Gill, S., O'Brien, P., Vardy, J., Friedenreich, C., Au, H., Brundage, M., Tu, D., Dhillon, H., et al (2008). The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group. Current Oncology, 15(6), 8-16. [More Information]

2007

  • Vardy, J., Schagen, S. (2007). Cognitive Dysfunction in People with Cancer. Lancet Oncology, 8(10), 852-853. [More Information]
  • Vardy, J., Tannock, I. (2007). Cognitive Function After Chemotherapy in Adults with Solid Tumours. Critical Reviews in Oncology / Hematology, 63(3), 183-202. [More Information]
  • Vardy, J., Rourke, S., Tannock, I. (2007). Evaluation of Cognitive Function Associated With Chemotherapy: A Review of Published Studies and Recommendations for Future Research. Journal of Clinical Oncology, 25(17), 2455-2463. [More Information]
  • Joly, F., Vardy, J., Pintilie, M., Tannock, I. (2007). Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Annals of Oncology, 18(12), 1935-1942. [More Information]

2006

  • Vardy, J., Wong, K., Yi, Q., Park, A., Maruff, P., Wagner, L., Tannock, I. (2006). Assessing cognitive function in cancer patients. Supportive Care in Cancer, 14(11), 1111-1118. [More Information]
  • Vardy, J., Chiew, K., Galica, J., Pond, G., Tannock, I. (2006). Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. British Journal of Cancer, 94(7), 1011-1015. [More Information]
  • Winocur, G., Vardy, J., Binns, M., Kerr, L., Tannock, I. (2006). The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacology, Biochemistry and Behavior, 85(1), 66-75. [More Information]

2005

  • Vardy, J., Joshua, A., Clarke, S., Yarrow, P., Lin, B. (2005). Small blue cell tumors of the rectum: CASE 1. Ewing's sarcoma of the rectum. Journal of Clinical Oncology, 23(4), 910-912. [More Information]

2004

  • Stockler, M., Vardy, J., Pillai, A., Warr, D. (2004). Acetaminophen (Paracetamol) Improves Pain And Well-Being In People With Advanced Cancer Already Receiving A Strong Opioid Regimen: A Randomized, Double-Blind, Placebo-Controlled Cross-Over Trial. Journal of Clinical Oncology, 22(16), 3389-3394.
  • Vardy, J., Engelhardt, K., Cox, K., Jacquet, J., McDade, A., Boyer, M., Beale, P., Clarke, S., Stockler, M., Loneragan, R., Waugh, R., Clarke, S. (2004). Long-Term Outcome Of Radiological-Guided Insertion Of Implanted Central Venous Access Port Devices (Cvapd) For The Delivery Of Chemotherapy In Cancer Patients: Institutional Experience And Review Of The Literature. British Journal of Cancer, 91(6), 1045-1049.
  • Vardy, J., Tannock, I. (2004). Quality of cancer care. Annals of Oncology, 15(7), 1001-1006.

2002

  • Vardy, J., Wong, E., Izard, M., Clifford, A., Clarke, S. (2002). Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review. Anti-Cancer Drugs, 13(3), 327-330.

To update your profile click here. For support on your academic profile contact .